Latest News - Becton Dickinson
Top Corporates Hub
Becton Dickinson
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
27.08.2025 13:40
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tesla Stock 'Could Fall 90% Tomorrow,' Fund Manager Still Won't Buy — Here's Where He's Investing Instead
27.08.2025 10:46
Tesla Inc (NASDAQ:TSLA) stock has fallen 8% year-to-date in 2025 and some investors and analysts believe the stock remains overvalued with more room to fall. One of the top-performing fund managers thinks Tesla stock could have significant downside ...
Heartland Mid Cap Value Fund Q2 2025 Commentary
21.08.2025 11:20
Mid Cap Value Fund lost 0.22% in Q2, trailing the Russell Midcap Value Index, which was up 5.35%. Stock selection was responsible for most of our underperformance.
Becton Dickinson Director Acquires 660% More Stock
12.08.2025 10:12
Those following along with Becton, Dickinson and Company ( NYSE:BDX ) will no doubt be intrigued by the recent purchase...
BDX Q3 Deep Dive: Margin Expansion and Portfolio Moves Drive Positive Market Response
12.08.2025 07:22
Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $5.51 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.68 per share was 8.2% above analysts’ consensus estimates.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Trump Links Chip Tariff Relief to US Factory Plans
07.08.2025 12:29
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.6% and the actively trad
Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates
07.08.2025 11:40
Becton Dickinson (BDX) delivered earnings and revenue surprises of +7.60% and +0.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Becton Dickinson shares surge as Q3 earnings beat drives guidance hike
07.08.2025 11:17
Investing.com -- Becton Dickinson shares surged over 8% in premarket trading on Thursday after the medical technology company reported third-quarter earnings that exceeded analyst expectations and raised its full-year profit outlook, citing strong margin improvements driven by operational excellence initiatives.
Becton Dickinson: Fiscal Q3 Earnings Snapshot
07.08.2025 10:41
FRANKLIN LAKES, N.J. (AP) — Becton Dickinson and Co. (BDX) on Thursday reported fiscal third-quarter earnings of $574 million. On a per-share basis, the Franklin Lakes, New Jersey-based company said it had net income of $2. Earnings, adjusted for one-time gains and costs, were $3.68 per share.
BD Reports Third Quarter Fiscal 2025 Financial Results
07.08.2025 10:30
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025 third quarter, which ended June 30, 2025.
Becton, Dickinson and Company 2025 Q3 - Results - Earnings Call Presentation
07.08.2025 09:52
The following slide deck was published by Becton, Dickinson and Company in conjunction with their 2025 Q3 earnings call.
Becton, Dickinson and Company (BDX) Q3 2025 Earnings Call Transcript
07.08.2025 09:51
Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call August 7, 2025 8:00 AM ETCompany ParticipantsChristopher J.
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
07.08.2025 02:36
Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, […]
Auxier Asset Management Summer 2025 Market Commentary
06.08.2025 04:39
Markets have been a rollercoaster for investors in 2025, with every major benchmark starting the year down in the first quarter to all being up for the second quarter and year-to-date.
Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer
05.08.2025 12:02
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Sean Boyle as Chief Executive Officer.
BD announces $35m investment to expand prefilled syringe manufacturing in US
05.08.2025 11:07
The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
05.08.2025 10:50
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative's (HIRC) Resiliency Badging program.
Heartland Mid Cap Value Strategy Q2 2025 Commentary
28.07.2025 05:39
The Mid Cap Value portfolio lost 0.09% in the second quarter, trailing the Russell Midcap® Value Index, which was up 5.35%. Read more here.
BD announces wearable injector trial for subcutaneous delivery of biologics
24.07.2025 10:43
The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.